This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Author: Avi Kapoor | November 04, 2025 06:56am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Wolfe Research analyst Doug Leggate downgraded the rating for Civitas Resources, Inc. (NYSE:CIVI) from Outperform to Peer Perform. Civitas Resources shares closed at $28.20 on Monday. See how other analysts view this stock.
Deutsche Bank analyst Niall Alexander downgraded Alvotech (NASDAQ:ALVO) from Buy to Hold and slashed the price target from $14 to $8. Alvotech shares closed at $5.03 on Monday. See how other analysts view this stock.
Evercore ISI Group analyst Javier Escalante downgraded Kimberly-Clark Corporation (NASDAQ:KMB) from Outperform to In-Line and cut the price target from $150 to $120. Kimberly-Clark shares closed at $102.27 on Monday. See how other analysts view this stock.
BTIG analyst Justin Zelin downgraded the rating for TScan Therapeutics, Inc. (NASDAQ:TCRX) from Buy to Neutral. TScan Therapeutics closed at $1.24 on Monday. See how other analysts view this stock.
B of A Securities analyst Shaun Kelley downgraded DraftKings Inc. (NASDAQ:DKNG) from Buy to Neutral and cut the price target from $48 to $35. DraftKings shares closed at $30.57 on Monday. See how other analysts view this stock.